Clinical Trial Update: Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy of T cell-depleted allogeneic non-myeloablative stem cell transplantation; the study in Hodgkin lymphoma, Non-Hodgkin lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Leukemia
• Multiple Myeloma
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Snippet

Sponsor: David Rizzieri, MD | Conditions: Hodgkin's Disease, Non Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-06-02